NCT00290641
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +50 more
- Locations
-
- University of Minnesota Cancer Center Minneapolis, Minnesota, United States
Clinical trial condition
Epstein-Barr Virus Infections
Explore clinical trials studying Epstein-Barr Virus Infections. Study availability and eligibility vary by location and protocol.
692 public trials
114 recruiting studies
Epstein-Barr Virus Infections trial results
NCT00005985
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +29 more
- Locations
-
- University of Minnesota Cancer Center Minneapolis, Minnesota, United States
NCT00964821
- Conditions
- Anemia, Anemia, Aplastic, Blast Crisis, +73 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- City of Hope Medical Group Pasadena, California, United States
NCT01786135
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +22 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- City of Hope National Medical Center Duarte, California, United States
- Stanford Cancer Center Stanford, California, United States
- H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
NCT00309907
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Blast Crisis, Blastic Phase Chronic Myelogenous Leukemia, +86 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Children's Oncology Group Arcadia, California, United States
- Loma Linda University Medical Center Loma Linda, California, United States
- Children's Hospital Colorado Aurora, Colorado, United States
NCT00245037
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +81 more
- Locations
-
- Knight Cancer Institute at Oregon Health and Science University Portland, Oregon, United States
NCT00238433
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +37 more
- Locations
-
- Knight Cancer Institute at Oregon Health and Science University Portland, Oregon, United States
NCT01254578
- Conditions
- Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1, +96 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT00073918
- Conditions
- Anaplastic Large Cell Lymphoma, Blood Protein Disorders, Burkitt Lymphoma, +50 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
NCT00104923
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Blood Protein Disorders, +58 more
- Locations
-
- USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
- Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States
- M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States
- Joe Arrington Cancer Research and Treatment Center Lubbock, Texas, United States